Volume 144, Issue 5, Pages 933-944 (May 2013) Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment  Grace Lai–Hung Wong, Henry Lik–Yuen Chan, Hoi–Yun Chan, Pete Chi–Hang Tse, Yee–Kit Tse, Christy Wing–Hin Mak, Stanley King– Yeung Lee, Zoe Man–Yi Ip, Andrew Ting–Ho Lam, Henry Wing–Hang Iu, Joyce May–Sum Leung, Vincent Wai–Sun Wong  Gastroenterology  Volume 144, Issue 5, Pages 933-944 (May 2013) DOI: 10.1053/j.gastro.2013.02.002 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 The AUCs of CU-HCC, GAG-HCC, and REACH-B scores at (A) baseline and (B) 2 years to predict HCC. Gastroenterology 2013 144, 933-944DOI: (10.1053/j.gastro.2013.02.002) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Kaplan–Meier analysis of the cumulative incidence of HCC in patients according to (A) CU-HCC scores at baseline and 2 years: <5 at baseline, ≥5 at baseline and <5 at 2-year score, and ≥5 at both time points (overall comparison, P = .006); (B) GAG-HCC scores at baseline and 2 years: <101 at baseline, ≥101 at baseline and <101 at 2-year score, and ≥101 at both time points (overall comparison, P < .001); and (C) REACH-B scores at baseline and 2 years: <8 at baseline and/or 2 years (referent) and ≥8 at both time points (P = .056). Gastroenterology 2013 144, 933-944DOI: (10.1053/j.gastro.2013.02.002) Copyright © 2013 AGA Institute Terms and Conditions